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Abstract
Background: Environmental factors have been associated with the outbreak of chronic kidney disease (CKD). We 
evaluated the association of Cadmium (Cd) exposure with the risk of CKD in U.S. adults who participated in the 1999-
2006 National Health and Nutrition Examination Surveys (NHANES).
Methods: 5426 subjects ≥ 20 years were stratified for values of urinary and blood Cd and a multivariate logistic 
regression was performed to test the association between blood and urinary Cd, CKD and albuminuria (ALB) after 
adjustment for age, gender, race/ethnicity, body mass index and smoking habits.
Results: Subjects with urinary Cd > 1 mcg/g and subjects with blood Cd > 1 mcg/L showed a higher association with 
ALB (OR 1.63, 95% CI 1.23, 2.16; P = 0.001). Subjects with blood Cd > 1 mcg/L showed a higher association with both 
CKD (OR 1.48, 95% CI 1.01, 2.17; P = 0.046) and ALB (OR 1.41, 95% CI 1.10, 1.82; P = 0.007). An interaction effect on ALB 
was found for high levels of urinary and blood Cd (P = 0.014).
Conclusions: Moderately high levels of urinary and blood Cd are associated with a higher proportion of CKD and ALB 
in the United States population.
Background
Chronic exposure to Cadmium (Cd), an industrial and
environmental pollutant, can cause both renal proximal
tubular damage and decline in glomerular filtration rate
(GFR) in humans; this has been confirmed in experimen-
tal models [1,2]. After pulmonary and/or gastrointestinal
absorption, Cd binds to serum albumin and accumulates
in the liver, where it is complexed to a metal-binding pro-
tein with a high affinity for Cd, metallothionein-1 [3]. The
Cd-metallothionein-1 complex reaches the kidney where
it is filtered and accumulates in the proximal tubule,
whose cells possess transporters for free and bound
forms of Cd [4] and interferes with the tubular function.
Cadmium nephropathy is characterized by low molecu-
lar weight (LMW) proteinuria due to diminished intrare-
nal uptake and catabolism of filtered proteins. In
Cadmium nephropathy, proximal tubular dysfunction
persists until renal failure supervenes.
Although Cadmium nephropathy has been observed in
workers exposed to high levels of Cd, recent data suggest
that relatively low levels of exposure in people living in
polluted industrial areas increase the risk of tubular dys-
function [1]. Furthermore, analysis of the National Health
and Nutrition Examination Survey (NHANES) databases
have disclosed even in the general population the associa-
tion of Cd exposure with some clinical conditions [5-7].
In particular, the very recent paper by Navas-Acien et al
[8] has disclosed that marginally high levels of blood Cd
are significantly associated with kidney dysfunction.
However, blood Cd is considered to be a marker of the
acute, short term exposition, rather than the chronic one
which is much more relevant to Cadmium nephropathy
[9]. Since the urinary excretion of Cd is assumed to mir-
ror chronic exposition to Cd, and Navas-Acien did not
investigate this topic, we have specifically addressed
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whether an association exists between urinary Cd and
renal dysfunction.
We analyzed the association between blood and uri-
nary Cd levels and kidney abnormalities (chronic kidney
disease [CKD] and albuminuria [ALB]) among U.S. adults
who participated in the 1999-2006 NHANES surveys to
support the idea that Cd exposition of the general popu-
lation contributes to the epidemics of CKD in this popu-
lation.
Methods
The NHANES is a cross-sectional nationally representa-
tive survey of the noninstitutionalized U.S. civilian popu-
lation [10], and is regularly conducted in the U.S. by the
National Center for Health statistics. It consists of stan-
dardized questionnaires administered in the home by
trained interviewers followed by a detailed physical
examination at a Mobile Examination Center. Data from
the 1999-2000, 2001-2002, 2003-2004 and 2005-2006
NHANES surveys were available from the website http://
www.cdc.gov/nchs/nhanes.htm[10]. We limited our anal-
ysis to subjects ≥ 20 years of age. Data relevant to the
analysis included age, gender, race/ethnicity, body mass
index (BMI), self-reported information about smoking
habits.
A blood specimen was obtained from participants for
blood Cd and creatinine. An untimed urine sample was
obtained from a random subsample of participants for
urinary Cd, albumin and creatinine.
Exclusions for the current study included subjects with-
out the measurements necessary for our analysis, and
pregnant or menstruating women at the time of examina-
tion.
Cadmium concentrations were determined at the Envi-
ronmental Health Sciences Laboratory of the CDC
National Center for Environmental Health (NCEH) after
confirmation of no background contamination and using
extensive quality control procedures. For blood Cd mea-
surements, a PerkinElmer Model SIMAA 6000 simulta-
neous multi-element atomic absorption spectrometer
with Zeeman background correction was used. Urinary
Cd concentrations were determined using inductively
coupled plasma mass spectrometry.
The limit of detection for urinary Cd was 0.04 mcg/L;
of the study participants, 1.2% had urinary Cd levels
below this limit.
The limit of detection for blood Cd was 0.30 mcg/L in
NHANES 1999-2002 and 0.20 mcg/L in NHANES 2003-
2006: 17.0% and 5.3% of the study participants had blood
Cd levels below the limits of detection in NHANES 1999-
2002 and NHANES 2003-2006, respectively.
In our analysis urinary Cd levels have been expressed as
a urinary Cd-to-creatinine ratio (mcg/g creatinine).
Serum and urinary creatinine concentrations were
determined using the Jaffe kinetic alkaline picrate
method. Estimated GFR (eGFR) was calculated from
standardized serum creatinine using the CKD-EPI study
equation [11].
Since proper use of GFR estimating equations requires
a known calibration of the serum creatinine assays [12],
unstandardized serum creatinine from the 1999-2000
survey was corrected applying the following formula,
available from the NHANES website [10]:
Uncalibrated serum creatinine from the 2005-2006 sur-
vey has been corrected using the formula [10]:
No creatinine calibration was needed for the 2001-02
and 2003-04 surveys values.
Urinary albumin concentration has been determined
using a solid-phase fluorescent immunoassay.
CKD has been defined as an eGFR < 60 mL/min/1.73
m2; ALB as a urinary albumin-to-creatinine ratio (UACR)
≥ 20 mg/g for males and ≥ 30 mg/g for females; smoke by
self-reported data: participants who reported having
smoked ≥ 100 cigarettes during their lifetime were classi-
fied as smokers.
Significant differences in the relative frequencies of
CKD and ALB have been calculated by means of a multi-
variate logistic regression model including age, gender,
race/ethnicity, BMI and smoking habits.
Continuous variables were tested for normality of dis-
tribution by means of numerical methods (skewness and
kurtosis) and all resulted non normally distributed, so
their values were reported as median (interquartile
range). Categorical variables were reported as total num-
ber (percent). Linear relations between continuous vari-
ables have been evaluated by Spearman correlation. An
eGFR < 10 mL/min or > 130 mL/min have not been con-
sidered for linear analysis. Mann-Whitney and Kruskal-
Wallis tests have been performed for comparison of con-
tinuous variables between two or more groups, respec-
tively. When using the Kruskal-Wallis test, differences
between groups have been carried out by Mann-Whitney
tests for pairs of groups if the overall F was significant.
For comparisons between categorical variables the Chi-
square test has been used. The accepted level for a two-
tailed significant difference was P < 0.05. All statistical
analyses were performed by using the survey package in
the R statistical language to account for the complex sam-
pling design and weights in NHANES surveys. Figures
have been obtained with GraphPad Prism version 5.0
(GraphPad Software, San Diego, CA, USA).
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T h e  N H A N E S  s u r v e y  i s  s u b j e c t  t o  t h e  C D C / N C H S
Ethics Review Board (ERB) to ensure that appropriate
human subjects protections are provided, in compliance
with 45 CFR part 46.
Results
The overall analysis included 5426 subjects, whose char-
acteristics are shown in Table 1.
Urinary Cd levels were significantly higher in smokers
(0.39 (0.46) mcg/g) compared with non smokers (0.23
(0.25) mcg/g) (P < 0.001). Blood Cd levels were signifi-
cantly higher in smokers (0.60 (0.52) mcg/L) compared
with non smokers (0.30 (0.20 mcg/g) (P < 0.001). Further-
more, there was a positive correlation between blood
cotinine, a metabolite of nicotine, and both blood Cd (r =
0.44, P < 0.001) and urinary Cd (r = 0.12, P < 0.001).
Urinary Cd was higher in females (0.33 (0.38) mcg/g)
compared with males (0.25 (0.32) mcg/g) (P  < 0.001).
Blood Cd levels were similar between females (0.40 (0.33)
mcg/L) and males (0.40 (0.50) mcg/L) (P = 0.137).
Urinary and blood Cd were significantly related with
UACR (r = 0.22 for urinary Cd, r = 0.09 for blood Cd) and
eGFR (r = -0.32 for urinary Cd, r = - 0.15 for blood Cd) (P
< 0.001 for each correlation).
Urinary Cd was higher in subjects with CKD (0.40
(0.38) mcg/g) compared with subjects without CKD (0.28
(0.35) mcg/g) (P < 0.001) and in subjects with ALB (0.38
(0.44) mcg/g) compared with subjects without ALB (0.27
(0.34) mcg/g) (P < 0.001).
Blood Cd was higher in subjects with CKD (0.50 (0.40)
mcg/L) compared with subjects without CKD (0.40 (0.40)
mcg/L) (P < 0.001) and in subjects with ALB (0.50 (0.40)
mcg/L) compared with subjects without ALB (0.50 (0.40)
mcg/L) (P < 0.001).
The logistic regression analysis of the association
between blood and urinary Cd and CKD and ALB
adjusted for age, gender, race/ethnicity and BMI showed
a significant association between blood Cd levels > 1
mcg/L and both CKD (OR 1.48, 95% CI 1.01, 2.17) (P =
0.046) and ALB (OR 1.41, 95% CI 1.10, 1.82) (P = 0.007); a
significant association was also found between urinary
Cd levels > 1 mcg/g and ALB (OR 1.63, 95% CI 1.23, 2.16)
(P = 0.001) but not CKD (OR 0.70, 95% CI 0.47, 1.04) (P =
0.079).
The results of the univariate and multivariate regres-
sion models, including an analysis of the interaction
effect of urinary and blood Cd are shown in Table 2 and
Figure 1.
Finally, receiver operating characteristic (ROC) curves
were performed to test the predictivity of urinary and
blood Cd levels with regard to presence of CKD and ALB
(Figure 2).
The areas under the ROC (AUROC) curve for CKD
were 0.62 for urinary Cd (95% CI 0.60, 0.65) and 0.60
(95% CI 0.57, 0.62) for blood Cd. Urinary Cd showed a
sensitivity > 70% for levels ≥ 0.27 mcg/g and a specificity
> 70% for levels ≥ 0.44 mcg/g, while blood Cd showed a
sensitivity > 70% for levels ≥ 0.39 mcg/L and a specificity
> 70% for levels ≥ 0.55 mcg/L.
The areas under the ROC (AUROC) curve for ALB
were 0.60 for urinary Cd (95% CI 0.58, 0.62) and 0.57 for
blood Cd (95% CI 0.55, 0.59). Urinary Cd showed a sensi-
tivity > 70% for levels ≥ 0.24 mcg/g and a specificity > 70%
for levels ≥ 0.43 mcg/g, while blood Cd showed a sensitiv-
ity > 70% for levels ≥ 0.31 mcg/L and a specificity > 70%
for levels ≥ 0.54 mcg/L.
Discussion
Navas-Acien et al [8] have recently reported in the large
1999-2006 NHANES adult population, a representative
sample of the general United States adult population, the
existence of an association between renal dysfunction
and blood Cd supporting previous findings that Cd is a
nephrotoxin even at low level exposition [13]. In this
study we confirm, in the subset of the same NHANES
population who has urinary Cd data, that blood Cd is
associated with impaired renal function and proteinuria.
Table 1: Characteristics of the study population
Age (years) 47 (32)
Males 2644 (48.7%)
Race/ethnicity
- Mexican American 1226 (22.6%)
- Non Hispanic White 2740 (50.5%)
- Non Hispanic Black 1072 (19.8%)
- Other 388 (7.2%)
BMI (Kg/m2) 27.5 (7.4)
Smokers 2649 (48.8%)
eGFR (mL/min/1.73 m2) 98 (35)
Chronic kidney disease 447 (8.2%)
UACR (mg/g) 6.7 (9.3)
Albuminuria 772 (14.2%)
Blood Cd (mcg/L) 0.40 (0.38)
Urinary Cd (mcg/g) 0.29 (0.35)Ferraro et al. BMC Public Health 2010, 10:304
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Table 2: Results of the multivariate logistic regression
CKD ALB
OR 95% CI Sig. (P) OR 95% CI Sig. (P)
Urinary Cd - univariate model
Urinary Cd
- ≤ 1 mcg/g Ref Ref - Ref Ref -
- > 1 mcg/g 1.61 1.14, 2.28 0.007 2.23 1.72, 2.89 < 0.001
Urinary Cd - multivariate model
Urinary Cd
- ≤ 1 mcg/g Ref Ref - Ref Ref -
- > 1 mcg/g 0.70 0.47, 1.04 0.079 1.63 1.23, 2.16 0.001
Age (1 year) 1.12 1.11, 1.13 < 0.001 1.04 1.03, 1.04 < 0.001
Gender
- Female Ref Ref - Ref Ref -
- Male 1.28 1.01, 1.62 0.039 0.65 0.55, 0.77 < 0.001
BMI (1 Kg/m2) 1.03 1.01, 1.05 0.002 1.04 1.03, 1.05 < 0.001
Race/ethnicity
- Mexican american Ref Ref - Ref Ref -
- Non-hispanic white 3.50 2.00, 6.11 < 0.001 1.16 0.84, 1.62 0.371
- Non Hispanic black 2.65 1.82, 3.86 < 0.001 0.65 0.53, 0.80 < 0.001
- Other 1.89 1.20, 2.97 < 0.001 1.12 0.89, 1.42 0.325
Blood Cd - univariate model
Blood Cd
- ≤ 1 mcg/L Ref Ref - Ref Ref -
- > 1 mcg/L 0.96 0.70, 1.32 0.007 1.28 1.02, 1.61 0.034
Blood Cd - multivariate model
Blood Cd
- ≤ 1 mcg/L Ref Ref - Ref Ref -
- > 1 mcg/L 1.48 1.01, 2.17 0.046 1.41 1.10, 1.82 0.007
Age (1 year) 1.12 1.11, 1.13 < 0.001 1.04 1.03, 1.04 < 0.001
Gender
- Female Ref Ref - Ref Ref -
- Male 1.22 0.97, 1.54 0.094 0.67 0.56, 0.79 < 0.001Ferraro et al. BMC Public Health 2010, 10:304
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Although blood Cd increases promptly following expo-
sure, the blood Cd concentration is considered to be a
less reliable marker of health effects than the urinary
excretion [9], and actually most of the papers investigat-
ing renal toxicity by Cd have analyzed the urinary excre-
tion of the metal [14]. It seems that the chronic
accumulation of Cd in the renal cortex is responsible for
the nephrotoxicity [15], and the cortical content is mir-
rored by the urinary excretion of Cd [16].
Present data shows the association of marginally high
urinary Cd excretion with abnormal albuminuria, while
no relationship was evidenced with CKD (eGFR < 60 mL/
min/1.73 m2). ROC curve analysis shows a prediction of
urinary Cd for both CKD and albuminuria.
Urine concentrations above 10 mcg/g of creatinine are
considered evidence of excessive exposure to Cd [17],
although the U.S. Occupational Safety and Health
Administration considers 3 mcg/g of creatinine as the
safety standard for urinary Cd. Very few Americans are
exposed to such high levels of Cd: of the investigated sub-
jects in the 1999-2006 NHANES surveys, no one had uri-
nary Cd levels above 10 mcg/g and only 8 exceeded 3
mcg/g. However, our analysis suggest that even low uri-
nary levels of Cd, an order of magnitude lower than those
considered as toxic in industrial medicine, may have
adverse effects on the kidney and a much higher number
of Americans have such an urinary excretion of Cd (645
subjects [12.6%] had urinary Cd levels > 0.75 mcg/g in
our study). The suspect that a mild exposition to Cd, as
mirrored by urinary Cd levels in the same order of magni-
tude of the present one, is possibly responsible for renal
dysfunction was raised in a small post-menopausal
female population in Sweden [18]. Our study confirms
that this may be the case, proposing Cd as a potential, rel-
evant contributor to the epidemics of CKD observed
nowadays.
An association between kidney disease and Cd was first
noted at the end of the 19th century, but the distinctive
tubular proteinuria was not recognized until the 1940s
[19]. For a long period, however, it remained unclear
whether Cadmium nephropathy was the result of con-
comitant Lead nephropathy or of the effects of urinary
tract obstruction. As a matter of fact, Cd workers are fre-
quently exposed also to Pb that induces chronic tubu-
lointerstitial nephritis, and kidney stones are common
among Cd workers [20]. Nevertheless, the role of Cd as a
nephrotoxin in humans is now widely acknowledged [21]
and it is known that the relative mortality from kidney
disease is increased among Cd workers [22]. Since in the
1999-2006 NHANES surveys no question regarded renal
stones it was not possible to investigate whether nephro-
lithiasis played any role in the association between renal
dysfunction and Cd levels.
A study on a sub-sample of the presently investigated
population (NHANES 1999-2000, 2001-2002, 2003-2004)
has been published which discloses the association of
blood Cd, but not urinary Cd, with a modest elevation in
blood pressure levels [7]. These data suggest that the rela-
tionship between blood Cd and CKD (as here defined, i.e.
GFR < 60 mL/min/1.73 m2) is hemodynamic, thus highly
susceptible to acute effects as those possibly depending
on acute variations of blood Cd levels.
Besides industrial pollution, other sources of Cd expo-
sure are cigarette smoke, ingestion of polluted vegetables,
and ambient air in urban-industrialized areas [5,23,24].
The significant correlation we observed between blood
levels of cotinine and Cd may suggest that cigarette
smoking is responsible for such a low level exposure to
Cd. Cigarette smoke contains about 4000 chemical sub-
BMI (1 Kg/m2) 1.04 1.02, 1.06 < 0.001 1.04 1.02, 1.05 < 0.001
Race/ethnicity
- Mexican american Ref Ref - Ref Ref -
- Non-hispanic white 3.29 1.88, 5.76 < 0.001 1.15 0.83, 1.60 0.405
- Non Hispanic black 2.66 1.83, 3.88 < 0.001 0.64 0.52, 0.79 < 0.001
- Other 1.88 1.19, 2.95 0.006 1.10 0.87, 1.38 0.456
Interaction urinary/blood Cd
Urinary/blood Cd
- ≤ 1 mcg/g-1 mcg/L Ref Ref - Ref Ref -
- > 1 mcg/g-1 mcg/L 1.01 0.60, 1. 27 0.964 1.62 1.10, 2.38 0.014
Table 2: Results of the multivariate logistic regression (Continued)Ferraro et al. BMC Public Health 2010, 10:304
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stances, including toxic metals such as Cd. Smoking 20
cigarettes a day results in inhalation of an average 3.6-6.0
mcg of Cd [25]. It was shown that while the cigarette is
burning, 30% of Cd and 11% of Pb present in the whole
cigarette is released into the smoke; moreover, for Cd, as
opposite to Pb, there is a high positive correlation
between the metal content in cigarettes and tobacco and
its release into the smoke; and finally, subjects smoking
cigarettes containing the highest Cd amount have higher
blood Cd concentration than smokers of low Cd content
cigarette brands [26]. In Cd and Pb unpolluted areas, cig-
arette smoking may thus create a serious source of
chronic exposure to these metals, especially to Cd [25].
The strong points of our study include the well-charac-
terized NHANES datasets, large sample size, and U.S.
nationally representative data. Since several potential
confounders were collected as part of the NHANES, we
were able to examine the association between Cd expo-
sure and CKD and albuminuria - both well established
risk factors for end stage renal disease in the general pop-
ulation [27] - after adjustment for potential confounders.
Limitations include the fact that Cd urinary levels were
low, close to the detection limit of the instrument.. Since
the NHANES is a cross-sectional study it is not possible
to infer causality between risk factors and CKD. Further-
more, the concept of chronicity of the renal dysfunction
is vague since only a small subsample of the investigated
NHANES population underwent a second evaluation of
albuminuria. This may be relevant to the interpretation of
present results. Actually we cannot confirm that the albu-
minuria found to be associated with urinary Cd levels is
really chronic and irreversible. Typical markers of proxi-
mal tubular dysfunction such as β2-microglobulin, which
is considered as one of the best indicators of Cd-induced
nephropathy, could not be investigated since they were
not collected during the NHANES. Since albumin is han-
dled by the proximal tubule as a LMW protein, albumin-
uria per se could be a marker of a dysfunction in the
proximal tubule machinery for LMW protein reabsorp-
tion [28] which may not constitute a "chronic kidney dis-
ease" condition. The Cd-metallothionein-1 complexes
filtered through the glomerulus accumulate in the proxi-
mal tubule [4] where they interfere with the tubular func-
tion, and namely with the above machinery. In the typical
Cadmium nephropathy, proximal tubular dysfunction
persists until renal failure supervenes but this is consid-
ered to occur following much more relevant exposure to
Cd. It is not known if low level exposure to Cd induces an
irreversible dysfunction in tubular biology, more severe
than the simple interference with LMW protein reab-
Figure 1 Odds Ratios for CKD and ALB by levels of urinary and 
blood Cd. Circles represent CKD, triangles represent ALB.
Figure 2 ROC curves for ALB and CKD by levels of urinary and 
blood Cd. ROC curves for ALB (A) and for CKD (B) by levels of urinary 
and blood Cd.Ferraro et al. BMC Public Health 2010, 10:304
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sorption, or reverts after giving up exposition to Cd. This
interpretation requires experimental verification at these
low levels of exposure to Cd.
In conclusion, data from the large general population of
the NHANES suggest that the chronic exposition to low
l ev e l  C d  i s  a s s oc i a t e d  w i t h  a l b u m i n u r i a,  a  w e l l  k n o wn
marker of renal dysfunction and may concur in explain-
ing the epidemics of chronic kidney disease.
Conclusions
In a large sample of the general population, levels of uri-
nary and blood Cd below the accepted thresholds are
associated with a higher proportion of kidney disease and
albuminuria.
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